INS and metabolic syndrome: Male recipients with metabolic syndrome showed improvement in peripheral insulin sensitivity six weeks after receiving allogenic intestinal microbiota from lean donors, attributed to an increase in gut microbial diversity, including those related to butyrate-production [17].